Back to Results
First PageMeta Content
Health / Pharmacology / Amgen / Etanercept / Wyeth / Rheumatoid arthritis / Tumor necrosis factor-alpha / Biologic / Rheumatology / Medicine / Immunosuppressants / Biology


Open Document

File Size: 2,20 MB

Share Result on Facebook

City

Rockville / Lincoln / /

Company

Immunex Corporation / QAS / Amgen / /

Event

FDA Phase / /

Facility

American College of Rheumatology / Rockville Pike / /

IndustryTerm

manufacturing / clinical protocols / /

MedicalCondition

tumor necrosis factor receptor / lymphoma / polyarticular-course juvenile rheumatoid arthritis / inflammatory processes / ankylosing spondylitis / RA psoriatic arthritis / arthritis / measures RA disease / rheumatoid arthritis / reported lymphomas / tumor necrosis factor / normal inflammatory and immune responses / inflammation / lymphoma incidence / /

MedicalTreatment

clinical protocols / /

Organization

Food and Drug Administration / New Drugs Center / Ph. Director Division / American College of Rheumatology / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH / office of Therapeutics Research / Center for Biologics Evaluation and Research / Pharmacokinetics After administration / /

Person

Marc Walton / Hunt / /

Position

Director / CLINICAL PHARMACOLOGY General / /

Product

SC / ENBREL / sulfasalazine / MTX tablets / Bacteriostatic Water for Injection / azathioprine / mannitol / Etanercept / II0 / /

ProvinceOrState

Maryland / Indiana / California / /

Technology

alpha / Pharmacokinetics / hybridization / http / html / recombinant DNA technology / PDF / /

SocialTag